Form 20-F Evotec SE For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260408/ANBZD62C8Z22BZZ2229Q2ZZZCPBBZ2W23B82
Filed on: April 8, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
- APA Corporation announces second-quarter 2026 financial and operational results
- Arcosa, Inc. Announces Second Quarter 2026 Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
